The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Access to Data and Biospecimens, 2015Immunogenetic Determinants of Disease Risk in Parkinson’s Disease
Study Rationale:
There is growing indication that the immune system plays a role in the development and progression of Parkinson’s disease with recent genome-wide association studies identifying...
-
Improved Biomarkers and Clinical Outcome Measures, 2015Defining a PD-specific Breath Fingerprint of Underlying Inflammatory and Neurodegenerative Processes
Study Rationale:
Breath analysis has the potential to be a powerful non-invasive screening tool to help a clinician determine the need for additional more invasive tests, a tool...
-
Therapeutic Pipeline Program, 2015RQ-00000010 for Gastroparesis and Constipation in Parkinson’s Disease
Study Rationale:
Constipation and gastroparesis (slow stomach emptying) are common non-motor symptoms of Parkinson’s disease (PD). These symptoms cause troublesome gastrointestinal... -
Access to Data & Biospecimens, 2015Whole Genome Sequencing and Analysis of the PPMI Prodromal and Genetic Cohorts, PPMI Genetic Registry and the LRRK2 Cohort Consortium
Study Rationale:
This work aims to provide genetic information for the whole genome and assess the role of the identified genetic information in Parkinson disease. To do this...
-
Access to Data & Biospecimens, 2015Evaluation of Alpha-synuclein and Hemoglobin Levels in CSF, Plasma and Saliva samples from the BioFind Cohort
Study Rationale:
Alpha-synuclein pathology plays a major role in Parkinson’s disease (PD). Recent studies suggest that measurement of alpha-synuclein in biological fluids (e.g...
-
Research Grant, 2014Development of an MgluR4 PET Radioligand
Study Rationale:
mGluR4 is a glutamate receptor that is believed to be a potential therapeutic target for Parkinson’s disease (PD). Developing an imaging tracer may allow researchers...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.